Chiron Vaccines (CHIR) Release: SBL Vaccines Management Group To Acquire Swedish Operations
10/19/2005 5:11:14 PM
Chiron Vaccines, a business unit of California-based Chiron Corporation Inc, announces today that its Swedish management team will acquire its SBL Vaccines operations in Sweden.
Under the terms of the agreement SBL Vaccines will go forward as an independent Swedish company, backed by the leading venture capitalists 3i Plc and SEB Företagsinvest. The business will continue to be run by the existing management group led by Björn Sjöstrand, and will use the long-established SBL name. In consideration for the Swedish operations, SBL Vaccines will grant Chiron Vaccines marketing rights in the key European markets to its recently approved oral cholera vaccine, Dukoral®.
comments powered by